BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Marin JJG, Herraez E, Lozano E, Macias RIR, Briz O. Models for Understanding Resistance to Chemotherapy in Liver Cancer. Cancers (Basel) 2019;11:E1677. [PMID: 31671735 DOI: 10.3390/cancers11111677] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Li X, Wang Z, Zhang D, Zhao D, Ye J, Duan W, Duan L, Liu Q. Repeat hepatectomy for pediatric recurrent chemotherapy-resistant hepatoblastoma: a report of 18 cases. J Cancer Res Clin Oncol 2022. [PMID: 36038674 DOI: 10.1007/s00432-022-04291-9] [Reference Citation Analysis]
2 Abdelazeem NM, Sroor FM, Basyouni WM, Adel I, Tantawy MA. Synthesis and Evaluation of New 3,4-Dihydropyrimidin-2-(1 H )-Ones and -Thiones as Anti-Cancer Agents: In Vitro , Molecular Docking and SAR Studies. Polycyclic Aromatic Compounds. [DOI: 10.1080/10406638.2022.2108076] [Reference Citation Analysis]
3 Soni VK, Mehta A, Ratre YK, Chandra V, Shukla D, Kumar A, Vishvakarma NK. Counteracting Action of Curcumin on High Glucose-Induced Chemoresistance in Hepatic Carcinoma Cells. Front Oncol 2021;11:738961. [PMID: 34692517 DOI: 10.3389/fonc.2021.738961] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
4 Roy S, Banerjee P, Ekser B, Bayless K, Zawieja D, Alpini G, Glaser SS, Chakraborty S. Targeting Lymphangiogenesis and Lymph Node Metastasis in Liver Cancer. Am J Pathol 2021;191:2052-63. [PMID: 34509441 DOI: 10.1016/j.ajpath.2021.08.011] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Chowdhury MMH, Salazar CJJ, Nurunnabi M. Recent advances in bionanomaterials for liver cancer diagnosis and treatment. Biomater Sci 2021;9:4821-42. [PMID: 34032223 DOI: 10.1039/d1bm00167a] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
6 Marin JJ, Macias RI. Understanding drug resistance mechanisms in cholangiocarcinoma: assisting the clinical development of investigational drugs. Expert Opin Investig Drugs 2021;30:675-9. [PMID: 33934687 DOI: 10.1080/13543784.2021.1916912] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
7 Park DJ, Sung PS, Lee GW, Cho S, Kim SM, Kang BY, Hur W, Yang H, Lee SK, Lee SH, Jung ES, Seo CH, Ahn J, Choi HJ, You YK, Jang JW, Bae SH, Choi JY, Yoon SK. Preferential Expression of Programmed Death Ligand 1 Protein in Tumor-Associated Macrophages and Its Potential Role in Immunotherapy for Hepatocellular Carcinoma. Int J Mol Sci 2021;22:4710. [PMID: 33946835 DOI: 10.3390/ijms22094710] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Conde de la Rosa L, Garcia-Ruiz C, Vallejo C, Baulies A, Nuñez S, Monte MJ, Marin JJG, Baila-Rueda L, Cenarro A, Civeira F, Fuster J, Garcia-Valdecasas JC, Ferrer J, Karin M, Ribas V, Fernandez-Checa JC. STARD1 promotes NASH-driven HCC by sustaining the generation of bile acids through the alternative mitochondrial pathway. J Hepatol 2021;74:1429-41. [PMID: 33515644 DOI: 10.1016/j.jhep.2021.01.028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
9 Jin X, Gong L, Peng Y, Li L, Liu G. Enhancer-bound Nrf2 licenses HIF-1α transcription under hypoxia to promote cisplatin resistance in hepatocellular carcinoma cells. Aging (Albany NY) 2020;13:364-75. [PMID: 33290263 DOI: 10.18632/aging.202137] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
10 Massa A, Varamo C, Vita F, Tavolari S, Peraldo-Neia C, Brandi G, Rizzo A, Cavalloni G, Aglietta M. Evolution of the Experimental Models of Cholangiocarcinoma. Cancers (Basel) 2020;12:E2308. [PMID: 32824407 DOI: 10.3390/cancers12082308] [Cited by in Crossref: 40] [Cited by in F6Publishing: 48] [Article Influence: 20.0] [Reference Citation Analysis]
11 Ruwizhi N, Aderibigbe BA. Cinnamic Acid Derivatives and Their Biological Efficacy. Int J Mol Sci 2020;21:E5712. [PMID: 32784935 DOI: 10.3390/ijms21165712] [Cited by in Crossref: 50] [Cited by in F6Publishing: 40] [Article Influence: 25.0] [Reference Citation Analysis]
12 Yapasert R, Lertprasertsuk N, Subhawa S, Poofery J, Sripanidkulchai B, Banjerdpongchai R. Antitumor Efficacy of the Herbal Recipe Benja Amarit against Highly Invasive Cholangiocarcinoma by Inducing Apoptosis both In Vitro and In Vivo. Int J Mol Sci 2020;21:E5669. [PMID: 32784671 DOI: 10.3390/ijms21165669] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
13 Fernández-Barrena MG, Arechederra M, Colyn L, Berasain C, Avila MA. Epigenetics in hepatocellular carcinoma development and therapy: The tip of the iceberg. JHEP Rep 2020;2:100167. [PMID: 33134907 DOI: 10.1016/j.jhepr.2020.100167] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 13.5] [Reference Citation Analysis]
14 Dal Bo M, De Mattia E, Baboci L, Mezzalira S, Cecchin E, Assaraf YG, Toffoli G. New insights into the pharmacological, immunological, and CAR-T-cell approaches in the treatment of hepatocellular carcinoma. Drug Resistance Updates 2020;51:100702. [DOI: 10.1016/j.drup.2020.100702] [Cited by in Crossref: 13] [Cited by in F6Publishing: 30] [Article Influence: 6.5] [Reference Citation Analysis]
15 Mossenta M, Busato D, Dal Bo M, Toffoli G. Glucose Metabolism and Oxidative Stress in Hepatocellular Carcinoma: Role and Possible Implications in Novel Therapeutic Strategies. Cancers (Basel) 2020;12:E1668. [PMID: 32585931 DOI: 10.3390/cancers12061668] [Cited by in Crossref: 9] [Cited by in F6Publishing: 23] [Article Influence: 4.5] [Reference Citation Analysis]